Sort
53,477 grants matching “addiction”
Center for Adaptive Neurotechnologies
$1,153,191Jonathan Rickel Wolpaw · Wadsworth Center · P41 · FY2016 · EB
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder
$1,151,963Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2023 · AA
UAW Hazardous Material Worker Health and Safety Training (U45)
$1,151,509Darius D Sivin · International Union, Uaw Of Amer Afl-Cio · U45 · FY2023 · ES
Development of a Novel Chemokine Receptor Antagonist as a Treatment for Opioid Use Disorder
$1,151,331Michael R Ruff · Creative Bio-Peptides, Inc. · R44 · FY2021 · DA
Neurobiology Of Relapse To Opiate and Psychostimulant Drugs
$1,150,973Yavin Shaham · National Institute On Drug Abuse · ZIA · FY2017 · DA
Unit of Neuromodulation and Synaptic Integration
$1,150,191Hugo Tejeda · National Institute Of Mental Health · ZIA · FY2021 · MH
California-Arizona Clinical Trials Network Node
$1,150,000University Of California San Francisco · U10 · FY2005 · DA
Clinical Trials Network: Greater New York Node
$1,150,000Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2010 · DA
Development and Implementation of a Culturally Centered Opioid Prevention Intervention for American Indian/Alaska Native Young Adults in California
$1,149,956Elizabeth J D'amico · Rand Corporation · UH3 · FY2022 · DA
Preclinical optimization of a gene therapy for erythromelalgia and chronic pain
$1,149,467Fernando Aleman Guillen · Navega Therapeutics, Inc. · U44 · FY2023 · NS
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$1,149,228Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2018 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2018 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2020 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2017 · DA
The Impact of HIV Infection on Immunologic, Transcriptomic, and Metabolomic Signatures of Medication-Assisted Therapy for Opioid Addiction
$1,148,831Sandra Ann Springer · Yale University · R01 · FY2019 · DA
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$1,148,752Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2011 · DA
The National Drug Abuse Treatment Clinical Trials Network
$1,148,687Roger D. Weiss · Mclean Hospital · UG1 · FY2019 · DA
Clinical Trials Network Mid-Atlantic Collaborative Group
$1,148,625Maxine L Stitzer · Johns Hopkins University · U10 · FY2012 · DA
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$1,148,343Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2017 · DA
Clinical Trials Network, Ohio Valley Node U10DA013732
$1,148,296T John Winhusen · University Of Cincinnati · U10 · FY2014 · DA
Development of a Neonatal Abstinence Syndrome Therapy
$1,148,201Rick Hawkins · Mu Therapeutics, Inc. · R44 · FY2019 · DA
Clinical Trials Network Mid-Atlantic Collaborative Group
$1,147,669Maxine L Stitzer · Johns Hopkins University · U10 · FY2011 · DA
Rapid Actionable Data for Opioid Response in Kentucky (RADOR-KY)
$1,147,127Svetla Stefanova Slavova · University Of Kentucky · R01 · FY2025 · DA
Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails
$1,146,403Melissa Jean Zielinski · Univ Of Arkansas For Med Scis · R33 · FY2025 · DA
CENTER FOR STUDY OF OPIOID RECEPTORS AND DRUGS OF ABUSE
$1,146,251University Of California Los Angeles · P50 · FY2001 · DA